| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/16/2003 | CA2453176A1 Eubacterial host cells devoid of n-terminal formylation and said host cells being useful for the production of proteins and peptides |
| 01/16/2003 | CA2453173A1 Mycobacterial antigens expressed during latency |
| 01/16/2003 | CA2453098A1 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 01/16/2003 | CA2453075A1 Drug metabolizing enzymes |
| 01/16/2003 | CA2453062A1 Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 01/16/2003 | CA2452695A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | CA2452580A1 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| 01/16/2003 | CA2452501A1 Secreted proteins |
| 01/16/2003 | CA2452359A1 Expression vectors encoding bacteriophage signal peptides |
| 01/16/2003 | CA2452315A1 Expression of functional human olfactory cyclic nucleotide gated (cng) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 01/16/2003 | CA2452241A1 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | CA2452119A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | CA2451492A1 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 01/16/2003 | CA2451395A1 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | CA2451374A1 Aggrecanase molecules |
| 01/16/2003 | CA2450867A1 Method of modifying enzyme and oxidoreductase variant |
| 01/16/2003 | CA2450236A1 Phage displayed pdz domain ligands |
| 01/16/2003 | CA2450185A1 Use of a tyrosine recombinase for genetic engineering |
| 01/15/2003 | EP1275729A1 Process for producing l-amino acid via fermentation method |
| 01/15/2003 | EP1275725A1 Use of the nucleotide sequence of the lactobacillus casei lactose operon promoter for regulating gene expression by means of an antiterminator protein |
| 01/15/2003 | EP1275723A1 Recombinant D-hydantoin hydrolases and N-carbamyl-D-amino acid hydrolases, and DNA encoding them; uses thereof for producing D-amino acids |
| 01/15/2003 | EP1275721A1 Alpha 1,4-n-acetylgalactosamine transferase gene and process for producing this enzyme and n-acetylgalactosamine-containing complex carbohydrate |
| 01/15/2003 | EP1275720A2 Histidyl-trna synthetase of staphylococcus aureus |
| 01/15/2003 | EP1275716A2 Modified DNA molecule, recombinant containing the same thing, and uses thereof |
| 01/15/2003 | EP1275714A1 Alpha 1,2-fucosyltransferase and process for producing fucose-containing complex carbohydrate |
| 01/15/2003 | EP1275711A1 Lipase/acyltransferase from Candida parapsilosis |
| 01/15/2003 | EP1275710A1 The device for cultivating cordyceps sinensis and method for cultivating it and the uses thereof |
| 01/15/2003 | EP1274853A1 Materials and methods relating to immune responses to fusion proteins |
| 01/15/2003 | EP1274849A2 Protein phosphatases |
| 01/15/2003 | EP1274845A2 Lipid binding protein 3 |
| 01/15/2003 | EP1274844A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/15/2003 | EP1274843A1 New lipid binding protein 2 |
| 01/15/2003 | EP1274842A2 Lipid binding protein 4 |
| 01/15/2003 | EP1274841A2 Regulation of human cyslt2-like gpcr protein |
| 01/15/2003 | EP1274839A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 01/15/2003 | EP1274836A1 Lactic acid bacteria overproducing exopolysaccharides |
| 01/15/2003 | EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2003 | EP1274730A2 Integrin/adhesion antagonists |
| 01/15/2003 | EP1274729A2 G protein coupled receptor |
| 01/15/2003 | EP1274728A2 Methods and compositions for the prevention and treatment of anemia |
| 01/15/2003 | EP1274727A1 Nk-2 homeobox transcription factor |
| 01/15/2003 | EP1274726A2 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274698A1 Percyquinnin, a process for its production and its use as a pharmaceutical |
| 01/15/2003 | EP1274318A1 Cultured protein hydrolysate |
| 01/15/2003 | EP1274305A2 Aids ancestral viruses and vaccines |
| 01/15/2003 | EP1274302A1 Cyclohexanediol cryoprotectant compounds |
| 01/15/2003 | EP0751986B1 Method for increasing plasmid yield |
| 01/15/2003 | EP0671927B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/15/2003 | CN1391614A Method for increasing yield of recombinant proteins in microbial fermentation processes |
| 01/15/2003 | CN1391611A Novel phenol oxidizing enzymes |
| 01/15/2003 | CN1391610A BASB118 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391581A Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 01/15/2003 | CN1391579A HEV antigenic peptide and its method |
| 01/15/2003 | CN1391480A Compositions and methods for treatment of allergic disorders |
| 01/15/2003 | CN1390945A Microorgan to produce fructose transferase and fructose oligosaccharlde thereby and process thereof |
| 01/15/2003 | CN1390942A Glucanase gene and lichenbacillus |
| 01/15/2003 | CN1390933A Process for preparing fragilis Kluyveromyce cell lactase |
| 01/15/2003 | CN1098929C Cultivating equipment, cultivating method and application of cordy ceps |
| 01/15/2003 | CN1098928C Pollution treating method in cultivating spirulina |
| 01/14/2003 | US6506956 Biodegradation |
| 01/14/2003 | US6506893 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 01/14/2003 | US6506591 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 01/14/2003 | US6506590 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 01/14/2003 | US6506589 Useful mutations of bacterial alkaline protease |
| 01/14/2003 | US6506588 Lipolytic enzymes |
| 01/14/2003 | US6506586 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 01/14/2003 | US6506585 Polypeptides having haloperoxidase activity |
| 01/14/2003 | US6506583 Culturing in glycerol, fructose, sorbose, mannitol, sorbitol, inositol, or glucose; fermentation; isolating nontoxic lipopolysaccharide produced by mutant |
| 01/14/2003 | US6506582 Extended by aspartic acid at 5' end and shortened at 3' end by one to eight amino acids; nonimmunogenic; binds CD4 lymphocytes |
| 01/14/2003 | US6506581 Nucleotide sequence of the Haemophilus influenzae Rd genome, fragments thereof, and uses thereof |
| 01/14/2003 | US6506579 Increasing production of proteins in gram-positive microorganisms using SecG |
| 01/14/2003 | US6506566 Screening enzymatic polypeptides for use in detergents; obtain microorganism expressing polypeptides, incubate with detergent, expose to binding protein, separate bound complex, isolate and propagate genome coding enzymatic variant |
| 01/14/2003 | US6506560 Cloned DNA polymerases from Thermotoga and mutants thereof |
| 01/14/2003 | US6506559 Molecular hybridization of complementary strands |
| 01/14/2003 | US6506426 Method for preparing a cheese product |
| 01/14/2003 | US6506388 Treating pollinosis using substance obtained by dissolving cell wall of corynebacterlum glutamicum with one of glucosi-dase and endopeptidase in isotonic solution medium, separa-ting protoplasts and treating with the other enzyme |
| 01/14/2003 | CA2027355C Yeast promoter |
| 01/09/2003 | WO2003002749A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 01/09/2003 | WO2003002738A1 Methods and materials for generating genetic disruptions in bacterial cells |
| 01/09/2003 | WO2003002730A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | WO2003002728A2 Prevention of retrogradation of starch |
| 01/09/2003 | WO2003002722A2 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | WO2003002721A2 Compositions and methods for inferring a response to a statin |
| 01/09/2003 | WO2003002711A2 A NOVEL GROUP OF α-AMYLASES AND A METHOD FOR IDENTIFICATION AND PRODUCTION OF NOVEL α-AMYLASES |
| 01/09/2003 | WO2003002709A2 Novel technology for genetic mapping |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002609A2 Dual-specific ligand and its use |
| 01/09/2003 | WO2003002608A1 Humanized antibody against fibroblast growth factor-8 and fragment of the antibody |
| 01/09/2003 | WO2003002604A2 G protein coupled receptors and dna sequences thereof |
| 01/09/2003 | WO2003002603A1 Novel neuropeptide y-like peptide |
| 01/09/2003 | WO2003002598A2 Peptides for use as translocation factors |
| 01/09/2003 | WO2003002549A1 Eurotinone and derivatives thereof, method for the production and use of the same |
| 01/09/2003 | WO2003002534A1 Bis-piperidines |
| 01/09/2003 | WO2003002131A1 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic |
| 01/09/2003 | WO2003002066A2 Glycosylated kinamycins and methods of making and using them |
| 01/09/2003 | WO2003001927A1 Capsules containing vital cells or tissues |
| 01/09/2003 | WO2002092825A3 Retroviral vectors for gene therapy |